John Sherman, MD
Obstetrics & Gynecology · Georgetown, TXNPI 1871574590
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,550 of the $6,730 with a category attached, or 67.6%. Pfizer accounts for 75.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $5,489 and has fallen 96.1% since, to $213 in 2025.
Across 78 payments — averaging $86.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$5K
- AbbVie$959
- Organon$153
- Boston Scientific$137
- Coopersurgical, Inc.$124
- Sumitomo Pharma America, Inc.$85
- plus $176 from 8 others
Across 273 payments — averaging $3322.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$467K
- GSK$363K
- AbbVie$62K
- Bayer$15K
What the payments were for
- Consulting fees$4,55068%
- Travel & lodging$3245%
- Food & beverage$1,85628%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $5,096 |
| AbbVie | 54 | $959 |
| Organon | 2 | $153 |
| Boston Scientific | 2 | $137 |
| Coopersurgical, Inc. | 1 | $124 |
| Sumitomo Pharma America, Inc. | 5 | $85 |
| Hologic Sales And Service, LLC | 3 | $34 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $23 |
| Axonics, Inc. | 1 | $21 |
| Biogen | 1 | $19 |
| Meditrina | 1 | $18 |
| Myovant Sciences Inc. | 1 | $17 |
| Intuitive Surgical | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,730 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 42 | $2,374 |
| Estradiol | 45 | $1,748 |
| Estradiol (Twice Weekly)Estradiol | 13 | $1,402 |
| Spironolactone | 15 | $193 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Georgetown
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.